75 related articles for article (PubMed ID: 1906639)
21. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
22. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
[TBL] [Abstract][Full Text] [Related]
23. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome.
Dakka N; Bellaoui H; Bouzid N; Khattab M; Bakri Y; Benjouad A
Pediatr Hematol Oncol; 2009 Jun; 26(4):216-31. PubMed ID: 19437324
[TBL] [Abstract][Full Text] [Related]
24. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
25. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
[TBL] [Abstract][Full Text] [Related]
26. First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study.
Domenech C; Mercier M; Plouvier E; Puraveau M; Bordigoni P; Michel G; Benoit Y; Leverger G; Baruchel A; Bertrand Y
Eur J Cancer; 2008 Nov; 44(16):2461-9. PubMed ID: 18804997
[TBL] [Abstract][Full Text] [Related]
27. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
Goldberg JM; Silverman LB; Levy DE; Dalton VK; Gelber RD; Lehmann L; Cohen HJ; Sallan SE; Asselin BL
J Clin Oncol; 2003 Oct; 21(19):3616-22. PubMed ID: 14512392
[TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemia.
Kim JM; Fang J; Rheingold S; Aplenc R; Wasserman R; Grupp SA
Cancer Res; 2002 Aug; 62(15):4212-6. PubMed ID: 12154021
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma.
Lerede T; Bassan R; Rossi A; Di Bona E; Rossi G; Pogliani EM; Motta T; Torri V; Buelli M; Comotti B; Viero P; Rambaldi A; Cortelazzo S; Rodeghiero F; Barbui T
Haematologica; 1996; 81(5):442-9. PubMed ID: 8952158
[TBL] [Abstract][Full Text] [Related]
30. Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience.
Thomas X; Olteanu N; Charrin C; Lhéritier V; Magaud JP; Fiere D
Am J Hematol; 2001 Jun; 67(2):73-83. PubMed ID: 11343378
[TBL] [Abstract][Full Text] [Related]
31. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
32. Mediastinal mass and malignant pleural effusion in an aleukemic case with pre-B acute lymphoblastic leukemia.
Pei SN; Kuo CY; Ma MC; Wang MC
J Pediatr Hematol Oncol; 2009 Feb; 31(2):139-41. PubMed ID: 19194202
[TBL] [Abstract][Full Text] [Related]
33. The age incidence of childhood B-cell precursor acute lymphoblastic leukemia in Mexico City.
Bernaldez-Rios R; Ortega-Alvarez MC; Perez-Saldivar ML; Alatoma-Medina NE; Del Campo-Martinez Mde L; Rodriguez-Zepeda Mdel C; Montero-Ponce I; Franco-Ornelas S; Fernandez-Castillo G; Nuñez-Villegas NN; Taboada-Flores MA; Flores-Lujano J; Argüelles-Sanchez ME; Juarez-Ocaña S; Fajardo-Gutierrez A; Mejia-Arangure JM
J Pediatr Hematol Oncol; 2008 Mar; 30(3):199-203. PubMed ID: 18376281
[TBL] [Abstract][Full Text] [Related]
34. The potential use of basigin (CD147) as a prognostic marker in B-cell precursor acute lymphoblastic leukaemia.
de Vries JF; Te Marvelde JG; Wind HK; van Dongen JJ; van der Velden VH
Br J Haematol; 2010 Sep; 150(5):624-6. PubMed ID: 20497175
[No Abstract] [Full Text] [Related]
35. A comparative analysis of cytoplasmic mu (C mu) expression in acute lymphoblastic leukemia by molecular and immunologic techniques. Identification of leukemia cases expressing C mu mRNA transcripts in the absence of detectable C mu proteins.
Little JV; Foucar K; Duncan MH; Crago SS; McConnell TS; Griffith B; Chen IM; Vogler LB; Willman CL
Am J Clin Pathol; 1992 Jun; 97(6):885-92. PubMed ID: 1595611
[TBL] [Abstract][Full Text] [Related]
36. Horner syndrome in a newly diagnosed patient with high risk precursor B-cell acute lymphoblastic leukemia.
Fountaine TJ; Miller B; Khalifa YM; Andolina JR
Pediatr Blood Cancer; 2012 Aug; 59(2):344. PubMed ID: 22232083
[No Abstract] [Full Text] [Related]
37. Outcome of B-Cell Acute Lymphoblastic Leukemia in Brazilian Children: Immunophenotypical, Hematological, and Clinical Evaluation.
Cézar RS; Cerqueira BA; da Paz Sde S; Barbosa CG; de Moura Neto JP; Barreto JH; Goncalves Mde S
J Pediatr Hematol Oncol; 2015 Aug; 37(6):423-8. PubMed ID: 26056790
[TBL] [Abstract][Full Text] [Related]
38. The pretreatment DNA labelling index of the blast cells of patients with acute lymphoblastic leukaemia as a prognostic factor in the outcome of treatment: the concept of 'G-0 acute leukaemia'.
Béjar-Lozano C; Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Marín-López A
Clin Lab Haematol; 1989; 11(4):339-48. PubMed ID: 2605875
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic pseudocyst secondary to chemotherapy for acute lymphoblastic leukaemia: successful percutaneous drainage.
Sierra J; Marti JM; Bataller R; Calvet X; Bru C; Grañena A; Rozman C
Eur J Med; 1992 Oct; 1(6):370-1. PubMed ID: 1341467
[No Abstract] [Full Text] [Related]
40. Study of foetal antigen in haematological malignancy.
Mukherjee N; Chatterjee D; Biswas TK; Sarkar M
J Assoc Physicians India; 1992 Jun; 40(6):384-7. PubMed ID: 1452563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
